AIPLA Direct Live: Senator Chris Coons

July 30, 2020 12:15 PM to 12:45 PM

Location

Virtual

Credits

N/A

Registration

Fee: Free

Register Now

Tune in on July 30, 2020, at 12:15 PM EDT for our next installment of AIPLA Direct LIVE and hear from US Senator Chris Coons. 



Meet Senator Coons

Chris has spent his career in the Senate focused on working across the aisle to get things done for the people of Delaware. In recent years, the Bipartisan Policy Center recognized Chris for his commitment to bipartisanship and awarded him its Legislative Action Award and the independent congressional tracking website GovTrack ranked Chris in the top three most productive Senators of both parties.

Chris serves on the Senate Appropriations, Foreign Relations, Judiciary, Small Business and Entrepreneurship, and Ethics committees. He is the vice chair of the Ethics Committee and the senior Democrat on two subcommittees: The Senate Judiciary Subcommittee on Intellectual Property and the Senate Appropriations Subcommittee on Financial Services and General Government.


Add to:

 

 

News

  • AIPLA Comments on Inventorship Guidance for AI-Assisted Inventions

    May 15, 2024

    Arlington, VA. May 10, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO in response to the recently-published Inventorship Guidance for AI-Assisted Inventions.
  • USPTO Building AIPLA Comments to USPTO on Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace

    May 14, 2024

    Arlington, VA. May 14, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the USPTO’s Request for Comment regarding Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace.
  • AIPLA Files Amicus Brief in REGENXBIO Inc. v. Sarepta Therapeutics, Inc.

    May 14, 2024

    Arlington, VA. May 10, 2024 - The American Intellectual Property Law Association (AIPLA) filed an amicus brief in support of neither party with the Court of Appeals for the Federal Circuit in REGENXBIO Inc. v. Sarepta Therapeutics, Inc., a case on appeal from the U.S. District Court for the District of Delaware. The district court held that cultured host cells containing a recombinant nucleic acid molecule were not eligible for patent protection under Section 101 of the Patent Act because the individual nucleic acid sequences used in the recombinant molecule were not modified or changed from their naturally occurring state.
  • Supreme Court Affirms Eleventh Circuit’s Ruling in Warner Chappell Music, Inc. v. Sherman Nealy

    May 9, 2024

    On May 9, 2024, the Supreme Court issued a 6-3 decision in Warner Chappell Music, Inc., et al. v. Sherman Nealy, et al., affirming the Eleventh Circuit’s ruling that, provided suit is timely filed under the discovery rule, copyright damages are recoverable for infringements occurring prior to the Copyright Act’s three-year statute of limitations. The majority opinion is consistent with the amicus brief filed by AIPLA on December 1, 2023. To read the opinion of the Court, please click here.
  • AIPLA Comments to Copyright Office on Group Registration of Two-Dimensional Artwork

    April 2, 2024

    Arlington, VA. April 1, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the U.S. Copyright Office's Notice of Proposed Rulemaking related to group registration of two-dimensional artwork.